Eric Bauman Email & Phone Number

East Lyme, Ct, Us

East Lyme, Ct, Us

New York, New York, Us

• Responsible for managing ~$1 billion R&D budget across Vaccines, Oncology, Drug Safety and the Chief Medical Officer. Key business partner to each Senior Vice President.• Led the R&D integration of the $17 billion Hospira acquisition and $11 billion Array acquisition. This effort included creating 3-year strategic growth plans, identifying synergy savings and creating an R&D operating model for each business.• Business Sponsor of digital project in pharmacovigilance to utilize Artificial Intelligence to improve throughput and reduce case reporting costs by 50%.• Lead talent development and planning for R&D Finance

New York, New York, Us

Full P&L responsibility including ~$4 billion in revenues for US Regional Business Units within Primary Care Business Unit. Brand Finance Lead for Eliquis, Viagra, Celebrex, Chantix and other key Primary Care medicines.

New York, New York, Us

• Responsible for managing the $2.5 billion clinical portfolio budget and partnering with the Development organization to implement its global strategic plan. • Created innovative economic models that directly influenced scientific operating decisions. As a result of one of these models, Pfizer changed the operating model for executing clinical trials.• Finance lead for the team that developed Pfizer’s strategy to accelerate its R&D efforts in Biotherapeutics.

New York, New York, Us

• Led the International Finance organization with responsibility for a $1 billion operating budget and expertise in business finance, procurement, tax, payroll and pensions.• Upgraded the Finance organization at all levels by reshaping the recruiting process and creating development opportunities for current colleagues.• Led the integration, sale or closure of six different locations in five different countries related to merger and acquisition activity.

New York, New York, Us

• Partnered with the Strategic Alliances organization to negotiate agreements, value equity investments and optimize the accounting treatment for over 75 major biotechnology research collaborations.• Developed an economic model used to optimize strategic alliance deal structures to negotiate both small and large collaborations.• Promoted four times in six years from Financial Analyst to Director as part of this role.

Norwalk, Connecticut, Us

• Designed valuation models, prepared S-1 registration statement and offering memoranda, and participated in investor meetings and presentations, relating to 10 major merger and acquisition projects totaling $4 billion.

Mba, Finance

Bs, Finance